These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11597991)

  • 1. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase.
    Soriano FG; Pacher P; Mabley J; Liaudet L; Szabó C
    Circ Res; 2001 Oct; 89(8):684-91. PubMed ID: 11597991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis.
    Zhou X; Patel D; Sen S; Shanmugam V; Sidawy A; Mishra L; Nguyen BN
    J Vasc Surg; 2017 Apr; 65(4):1161-1169. PubMed ID: 27288104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase.
    Mabley JG; Jagtap P; Perretti M; Getting SJ; Salzman AL; Virág L; Szabó E; Soriano FG; Liaudet L; Abdelkarim GE; Haskó G; Marton A; Southan GJ; Szabó C
    Inflamm Res; 2001 Nov; 50(11):561-9. PubMed ID: 11766996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta.
    Tasatargil A; Dalaklioglu S; Sadan G
    Pharmacology; 2004 Oct; 72(2):99-105. PubMed ID: 15331915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas.
    Wang LJ; Yu YH; Zhang LG; Wang Y; Niu N; Li Q; Guo LM
    Eur J Pharmacol; 2008 Nov; 597(1-3):75-80. PubMed ID: 18796303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) polymerase inhibition improves endothelin-1-induced endothelial dysfunction in rat thoracic aorta.
    Yilmaz B; Sahin P; Ordueri E; Celik-Ozenci C; Tasatargil A
    Ups J Med Sci; 2014 Aug; 119(3):215-22. PubMed ID: 24932781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase.
    Benkö R; Pacher P; Vaslin A; Kollai M; Szabó C
    Life Sci; 2004 Jul; 75(10):1255-61. PubMed ID: 15219813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes.
    Salum E; Kampus P; Zilmer M; Eha J; Butlin M; Avolio AP; Põdramägi T; Arend A; Aunapuu M; Kals J
    Cardiovasc Diabetol; 2012 Jul; 11():58. PubMed ID: 22631050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose) polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus.
    Choi SK; Galán M; Kassan M; Partyka M; Trebak M; Matrougui K
    Hypertension; 2012 May; 59(5):1060-8. PubMed ID: 22454481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro.
    Radovits T; Lin LN; Zotkina J; Gero D; Szabó C; Karck M; Szabó G
    Eur J Pharmacol; 2007 Jun; 564(1-3):158-66. PubMed ID: 17397824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite.
    Radovits T; Zotkina J; Lin LN; Bömicke T; Arif R; Gerö D; Horváth EM; Karck M; Szabó C; Szabó G
    Exp Biol Med (Maywood); 2007 Oct; 232(9):1204-12. PubMed ID: 17895528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.
    Garcia Soriano F ; Virág L; Jagtap P; Szabó E; Mabley JG; Liaudet L; Marton A; Hoyt DG; Murthy KG; Salzman AL; Southan GJ; Szabó C
    Nat Med; 2001 Jan; 7(1):108-13. PubMed ID: 11135624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase inhibition reverses nitrergic neurovascular dysfunctions in penile erectile tissue from streptozotocin-diabetic mice.
    Nangle MR; Cotter MA; Cameron NE
    J Sex Med; 2010 Oct; 7(10):3396-403. PubMed ID: 20456626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of endothelium-derived hyperpolarizing factor (EDHF) up-regulation in endothelial dysfunction in aorta in diabetic rats.
    Csanyi G; Lepran I; Flesch T; Telegdy G; Szabo G; Mezei Z
    Pharmacol Rep; 2007; 59(4):447-55. PubMed ID: 17901574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation.
    Szabó C; Pacher P; Zsengellér Z; Vaslin A; Komjáti K; Benkö R; Chen M; Mabley JG; Kollai M
    Mol Med; 2004; 10(1-6):28-35. PubMed ID: 15502880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate improves vascular endothelial function in diabetic mice.
    Xin R; An D; Li Y; Fu J; Huang F; Zhu Q
    Biomed Pharmacother; 2019 Apr; 112():108722. PubMed ID: 30970521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes.
    Pacher P; Liaudet L; Soriano FG; Mabley JG; Szabó E; Szabó C
    Diabetes; 2002 Feb; 51(2):514-21. PubMed ID: 11812763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone-induced endothelial dysfunction of rat aorta: role of poly(ADP-ribose) activation.
    Tasatargil A; Tekcan M; Celik-Ozenci C; Ece Gungor N; Dalkiran B
    J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):127-37. PubMed ID: 19713411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.